Why Engagement—Not Product—Will Define the Future of Femtech
Product innovation isn’t the bottleneck. Engagement is.
Most femtech companies are focused on building better products. Better diagnostics. Better tracking. More personalized insights.
And in many ways, that focus makes sense. The last decade of digital health innovation has been defined by what we can build—what data we can surface, what patterns we can detect, what experiences we can digitize. But as the category matures, a different constraint is beginning to surface.
The defining challenge in women’s health isn’t product innovation. It’s sustained engagement.
Women’s health is not a single moment problem. It is cyclical, longitudinal, and shaped by changing physiology, energy, and context over time. The experience of someone navigating perimenopause, for example, is not static from month to month—let alone year to year. Stress tolerance shifts. Cognitive capacity fluctuates. Priorities evolve. Identity itself often comes into question.
And yet, many digital health products are still designed around relatively stable patterns of use—assuming consistency in attention, motivation, and capacity. In practice, that assumption breaks down quickly.
Across digital health, engagement drop-off is well documented. Research consistently shows that a majority of users discontinue health apps within the first 30 to 90 days, with long-term retention remaining a persistent challenge across categories.
In women’s health, where meaningful engagement often spans years—not weeks—this gap becomes even more consequential.
My work sits at the intersection of women’s health and customer success—two domains that both depend on sustained engagement over time. One grounded in physiology, the other in systems and retention. From that vantage point, the disconnect becomes difficult to ignore.
The issue isn’t simply that engagement is low. It’s that engagement is being understood too narrowly. What works in short-term or transactional environments does not map cleanly onto long-term, physiology-driven experiences like women’s health. Reminders, nudges, and static content assume a level of consistency that many users simply don’t have access to—especially during periods of transition.
Engagement, in this context, is not simply a behavioral problem. It is shaped by something more dynamic—and less predictable.
As femtech continues to evolve, this gap will become more visible, not less. This challenge is already showing up at the company level. A majority of early-stage femtech ventures struggle to scale beyond initial funding, with industry estimates suggesting that as many as 70% fail to reach Series A—despite strong product innovation. The companies that succeed won’t just be those with better products. They will be the ones that can support users across changing capacity, shifting needs, and different stages of life—without assuming consistency where it doesn’t exist.
This is one of the central questions explored in the Q1 Metis Femtech Intelligence Brief. The brief examines how engagement is currently being approached across women’s health platforms—and where that approach begins to break down over time.
If you’re building or operating in femtech, you can access the full brief here:
Download the Q1-2026 Metis Femtech Intelligence Brief
Engagement isn’t a feature. It’s the foundation.